Stemmatters provides contract development and manufacturing organisation (CDMO) services for cell and tissue-based therapies and blood-derived biologics. We are a vertically integrated company with resources and competences addressing all product development stages, from exploratory R&D to cGMP production and clinical batch release. Our domain of expertise is Regenerative Medicine and we have the ability to work across a wide range of cells and product types. Stemmatters’ offering is also sustained by an innovative biomaterial product platform supporting formulation of advanced therapies for multiple indications.
